SCHEMBL5588086

SCHEMBL5588086

CCCCCCCC(I)(I)c1cccc(O)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
ATM Q13315 1/20 0.45
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41
KAT8 Q9H7Z6 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
IAPP P10997 2/20 0.41
EP300 Q09472 2/20 0.41
KAT5 Q92993 2/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
CNR1 P21554 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587960 1.00 MEN1 (0.45) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL5587503 1.00 MEN1 (0.45) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL5588990 1.00 MEN1 (0.45) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL5586873 0.98 ALDH1A1 (0.42) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL5589369 0.93 IAPP (0.43) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL5588237 0.86 ALDH1A1 (0.39) ALDH1A1MAPTATMIAPP
SCHEMBL5588031 0.82 MEN1 (0.42) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL5587291 0.82 MEN1 (0.42) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL5589957 0.82 MEN1 (0.42) MEN1ALDH1A1MAPTHTTKMT2A
SCHEMBL29160984 0.82 CNR1 (0.43) MEN1ALDH1A1MAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 MEN1 3377/4885ALDH1A1 2181/4885MAPT 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.